Search Within

Joseph G Jurcic

Formats
  1. Meeting Abstract (69)
  2. Journal Article (60)
  3. Book Section (3)
  4. Conference Paper (2)
Groups
  1. Department of Medicine (134)
  2. Hematologic Malignancies, Division of (134)
  3. Center for Hematologic Malignancies (112)
  4. Adult Leukemia (109)
  5. GSK Faculty (99)
  6. Hematologic Malignancies Research (95)

More Groups

People
  1. David Scheinberg (84)
  2. Peter Maslak (44)
  3. Steven Larson (33)
  4. Ronald Finn (26)
  5. Mark Heaney (23)
  6. Michael Mcdevitt (23)

More People

Years
  1. 2018 (1)
  2. 2016 (1)
  3. 2014 (2)
  4. 2013 (4)
  5. 2012 (9)
  6. 2011 (13)

More Years

Publications
  1. Blood (47)
  2. Journal of Clinical Oncology (13)
  3. Journal of Nuclear Medicine (8)
  4. Cancer Biotherapy and Radiopharmaceuticals (6)
  5. Cancer Chemotherapy and Biological Response Modifiers (4)
  6. Clinical Cancer Research (4)

More Publications

Publishers
  1. American Society of Hematology (48)
  2. American Society of Clinical Oncology (13)
  3. Elsevier Inc. (12)
  4. Society of Nuclear Medicine (8)
  5. Mary Ann Liebert, Inc (6)
  6. Springer (6)

More Publishers

Results (134)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A population-based study in acute promyelocytic leukemia (APL) suggests a higher early death rate and lower overall survival than commonly reported in clinical trials: Data from the Surveillance, Epidemiology, and End Results (SEER) program and the New York State Cancer Registry in the United States between 1992-2007
    Journal Article

    Park, J. H.; Panageas, K. S.; Schymura, M. J.; Qiao, B.; Jurcic, J. G.; Rosenblat, T. L.; Altman, J. K.; Douer, D.; Rowe, J. M.; Tallman, M. S.
    Blood (2010)

    Fulltext@MSK | Save
  • Characteristic proinflammatory serum cytokine profiles in patients with B-Cell chronic lymphocytic leukemia
    Meeting Abstract

    Harding, J. J.; Yeh, R.; Nikhamin, Y.; Frattini, M.; Lamanna, N.; Jurcic, J. G.; Heaney, M.; Brentjens, R.
    Blood (2010)

    Fulltext@MSK | Save
  • High mitochondrial membrane potential identifies patients with myeloproliferative neoplasms with a more aggressive natural history
    Meeting Abstract

    Gardner, J. R.; Abdel-Wahab, O.; Frattini, M.; Jurcic, J. G.; Knapp, K.; Rosenblat, T. L.; Soff, G. A.; Levine, R.; Heaney, M.
    Blood (2010)

    Fulltext@MSK | Save
  • Sequential cytarabine and α-particle immunotherapy with bismuth-213-lintuzumab (HuM195) for acute myeloid leukemia
    Journal Article

    Rosenblat, T. L.; McDevitt, M. R.; Mulford, D. A.; Pandit-Taskar, N.; Divgi, C. R.; Panageas, K. S.; Heaney, M. L.; Chanel, S.; Morgenstern, A.; Sgouros, G.; more...
    Clinical Cancer Research (2010)

    Fulltext@MSK | Save
  • Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemia
    Journal Article

    Maslak, P. G.; Dao, T.; Krug, L. M.; Chanel, S.; Korontsvit, T.; Zakhaleva, V.; Zhang, R.; Wolchok, J. D.; Yuan, J.; Pinilla-Ibarz, J.; more...
    Blood (2010)

    Fulltext@MSK | Save
  • Discovery and validation of a novel class of small molecule inhibitors of the CDC7 kinase: Modulation of tumor cell growth in vitro and in vivo
    Meeting Abstract

    Frattini, M. G.; Shum, D.; O'Dwyer, K. M.; Brentjens, R. J.; Maslak, P.; Heaney, M.; Jurcic, J. G.; Djaballah, H.; Kelly, T. J.
    Blood (2009)

    Fulltext@MSK | Save
  • Clinical implementation of a novel high-throughput screen of primary leukemia cells to customize therapy for relapsed/refractory acute myeloid leukemia (AML)
    Meeting Abstract

    O'Dwyer, K. M.; Shum, D.; Heaney, M.; Brentjens, R. J.; Maslak, P.; Jurcic, J. G.; Djaballah, H.; Frattini, M. G.
    Blood (2009)

    Fulltext@MSK | Save
  • Prolonged exposure to lintuzumab monotherapy in acute myeloid leukemia and myelodysplastic syndromes - Results of a phase 1 trial
    Meeting Abstract

    Raza, A.; Jurcic, J. G.; Feldman, E. J.; Maris, M.; Stephenson, J.; Frankel, A. E.; Cooper, M.; Wade, J.; Wood, B. L.; Galili, N.; more...
    Haematologica (2009)

    Fulltext@MSK | Save
  • Complete remissions observed in acute myeloid leukemia following prolonged exposure to lintuzumab: A phase 1 trial
    Journal Article

    Raza, A.; Jurcic, J. G.; Roboz, G. J.; Maris, M.; Stephenson, J. J.; Wood, B. L.; Feldman, E. J.; Galili, N.; Grove, L. E.; Drachman, J. G.; more...
    Leukemia and Lymphoma (2009)

    Fulltext@MSK | Save
  • Sequential therapy with fludarabine, high-dose cyclophosphamide, and rituximab in previously untreated patients with chronic lymphocytic leukemia produces high-quality responses: Molecular remissions predict for durable complete responses
    Journal Article

    Lamanna, N.; Jurcic, J. G.; Noy, A.; Maslak, P.; Gencarelli, A. N.; Panageas, K. S.; Heaney, M. L.; Brentjens, R. J.; Golde, D. W.; Scheinberg, D. A.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save